# Abbott Laboratories (ABT) — Q4-2024 Earnings Results

**Report date:** 2025-01-22 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2024

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Up 0.85%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.34 | N/A | +0.15% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management appears pleased with the EPS results, indicating a focus on cost management and operational improvements. However, they did not provide specific revenue guidance.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing efforts to improve operational efficiency.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Abbott Labs' earnings report shows a slight EPS beat, which led to a modest increase in the stock price. The market reacted positively, likely due to the better-than-expected earnings per share. However, the lack of revenue figures and guidance may leave investors cautious about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2024_